Literature DB >> 19818432

Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.

Massimiliano Di Filippo1, Alessandro Tozzi, Veronica Ghiglieri, Barbara Picconi, Cinzia Costa, Sabrina Cipriani, Michela Tantucci, Vincenzo Belcastro, Paolo Calabresi.   

Abstract

BACKGROUND: Trisomy 21 or Down syndrome (DS) is the most frequent genetic cause of mental retardation. There is limited insight into the biological basis for the cognitive and motor deficits in DS. Because the striatum plays a key role in the regulation and learning of voluntary movements and in cognitive processes, our study was aimed at investigating striatal synaptic transmission and plasticity in a well-accepted genetic model of DS.
METHODS: Electrophysiological recordings were performed in a corticostriatal slice preparation from trisomic (Ts65Dn) and wild-type mice. Synaptic properties and plasticity, long-term potentiation (LTP) and long-term depression (LTD), were investigated.
RESULTS: The basal electrophysiological properties of striatal principal spiny neurons and cholinergic interneurons were spared in the Ts65Dn mouse model of DS. Striatal principal spiny neurons from Ts65Dn mice maintained their ability to undergo LTP and LTD. Conversely, LTP was lost in striatal cholinergic interneurons of Ts65Dn mice. The loss of LTP in striatal cholinergic interneurons of Ts65Dn mice was accompanied by a severe impairment of endogenous cholinergic signaling within the striatum.
CONCLUSIONS: The intrastriatal cholinergic system that was thought to be spared in DS is functionally altered in the Ts65Dn genetic model of DS. Altered cholinergic transmission might play a critical role in the pathophysiology of motor and cognitive deficits in DS, leading to an abnormal processing of neuronal inputs within the basal ganglia. Targeting striatal cholinergic transmission might represent a new therapeutic strategy in DS. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818432     DOI: 10.1016/j.biopsych.2009.08.018

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

1.  A novel binding protein of single-minded 2: the mitotic arrest-deficient protein MAD2B.

Authors:  Xianfang Meng; Xiujuan Tian; Xiaolan Wang; Pan Gao; Chun Zhang
Journal:  Neurogenetics       Date:  2012-06-02       Impact factor: 2.660

2.  Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a.

Authors:  Aurore Thomazeau; Olivier Lassalle; Jillian Iafrati; Benoit Souchet; Fayçal Guedj; Nathalie Janel; Pascale Chavis; Jean Delabar; Olivier J Manzoni
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

Review 3.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

4.  Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: a diffusional kurtosis imaging study.

Authors:  Xingju Nie; Eric D Hamlett; Ann-Charlotte Granholm; Edward S Hui; Joseph A Helpern; Jens H Jensen; Heather A Boger; Heather R Collins; Maria F Falangola
Journal:  Magn Reson Imaging       Date:  2014-12-16       Impact factor: 2.546

Review 5.  New synaptic and molecular targets for neuroprotection in Parkinson's disease.

Authors:  Paolo Calabresi; Massimiliano Di Filippo; Antongiulio Gallina; Yingfei Wang; Jeannette N Stankowski; Barbara Picconi; Valina L Dawson; Ted M Dawson
Journal:  Mov Disord       Date:  2012-08-23       Impact factor: 10.338

6.  Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment.

Authors:  Nicolas Gutierrez-Castellanos; Beerend H J Winkelman; Leonardo Tolosa-Rodriguez; Benjamin Devenney; Roger H Reeves; Chris I De Zeeuw
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

7.  Age-related neurodegeneration and memory loss in down syndrome.

Authors:  Jason P Lockrow; Ashley M Fortress; Ann-Charlotte E Granholm
Journal:  Curr Gerontol Geriatr Res       Date:  2012-03-20

Review 8.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

9.  Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues.

Authors:  Pavel V Belichenko; Alexander M Kleschevnikov; Ann Becker; Grant E Wagner; Larisa V Lysenko; Y Eugene Yu; William C Mobley
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.

Authors:  Aarti Ruparelia; Frances Wiseman; Olivia Sheppard; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  J Biomed Res       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.